Article thumbnail

Efficient nano iron particle-labeling and noninvasive MR imaging of mouse bone marrow-derived endothelial progenitor cells

By Rong Chen, Hui Yu, Zhen-Yu Jia, Qun-Li Yao and Gao-Jun Teng


In this study, we sought to label mouse bone marrow-derived endothelial progenitor cells (EPCs) with Resovist® in vitro and to image them using 7.0 Tesla (T) magnetic resonance imaging (MRI). Mouse bone marrow-derived EPCs were cultured in endothelial basal medium with endothelial growth supplement. They were then characterized by immunocytochemistry, flow cytometry, and fluorescence quantitative polymerase chain reaction. Their functions were evaluated by measuring their uptake of 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine-labeled acetylated low-density lipoprotein (Dil-Ac-LDL), binding of fluorine isothiocyanate (FITC)-labeled Ulex europaeus agglutinin (UEA), and formation of capillary-like networks. EPCs were labeled with superparamagnetic iron oxide (SPIO) and their proliferation was then assessed in a water-soluble tetrazolium (WST-8)-based cell proliferation assay. Spin echo sequence (multislice, multiecho [MSME]) and gradient echo sequence (2D-FLASH) were used to detect differences in the numbers of labeled cells by 7.0 T MRI. The results showed that the cultured cells were of “cobblestone”-like shape and positive for CD133, CD34, CD31, von Willebrand factor, kinase domain receptor, and CD45, but negative for F4/80. They could take up Dil-Ac-LDL, bind FITC-UEA, and form capillary-like networks on Matrigel in vitro. Prussian-blue staining demonstrated that the cells were efficiently labeled with SPIO. The single-cell T2* effect was more obvious in the 2D-FLASH sequence than in the MSME sequence. Further, there were almost no adverse effects on cell vitality and proliferation. In conclusion, mouse bone marrow-derived EPCs can be efficiently labeled with SPIO and imaged with 7.0-T MRI. They may thus be traced by MRI following transplantation for blood vessel disorders and cancer treatment

Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles.
  2. (2007). Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis.
  3. (2006). Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res.
  4. Characteristics of bone marrowderived endothelial progenitor cells in aged mice.
  5. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells.
  6. Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.
  7. (2008). Endothelial progenitor cells for cancer gene therapy. Gene Ther.
  8. (2003). Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol.
  9. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.
  10. How can superparamagnetic iron oxides be used to monitor disease and treatment?
  11. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood.
  12. Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit model.
  13. Isolation of putative progenitor endothelial cells for angiogenesis.
  14. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med.